Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Royalty Pharma
RPRX
$25.8B
| $12.2M | ﹤0.01% |
339,362
-27,868
| -8% | -$923K |
|
|
BPMC
1427
CALL
DELISTED
Blueprint Medicines
BPMC
| $12.2M | ﹤0.01% |
+95,300
| New | +$9.9M |
|
1428
Moog Inc Class A
MOG.A
$13B
| $12.2M | ﹤0.01% |
67,477
+14,487
| +27% | +$2.54M |
|
1429
PUT
Dow Inc
DOW
$22.1B
| $12.2M | ﹤0.01% |
+460,000
| New | +$13.4M |
|
1430
Lithia Motors
LAD
$8.35B
| $12.2M | ﹤0.01% |
36,040
+12,717
| +55% | +$3.93M |
|
1431
Applied Industrial Technologies
AIT
$13.2B
| $12.2M | ﹤0.01% |
52,376
-14,241
| -21% | -$3.24M |
|
1432
Sabra Healthcare REIT
SBRA
$5.28B
| $12.2M | ﹤0.01% |
659,978
-526,038
| -44% | -$9.33M |
|
1433
OGE Energy
OGE
$9.54B
| $12.1M | ﹤0.01% |
273,706
+182,172
| +199% | +$8.08M |
|
1434
Omnicell
OMCL
$1.7B
| $12.1M | ﹤0.01% |
412,570
+32,832
| +9% | +$982K |
|
1435
Itron
ITRI
$4.49B
| $12.1M | ﹤0.01% |
91,903
+17,675
| +24% | +$2M |
|
1436
Coherent
COHR
$63.6B
| $12.1M | ﹤0.01% |
135,540
-26,280
| -16% | -$1.89M |
|
1437
ANI Pharmaceuticals
ANIP
$1.72B
| $12M | ﹤0.01% |
184,639
+45,359
| +33% | +$2.95M |
|
|
BCPC
1438
Balchem Corp
BCPC
$5.65B
| $12M | ﹤0.01% |
75,594
+26,274
| +53% | +$4.26M |
|
1439
Blue Owl Capital
OWL
$18.2B
| $12M | ﹤0.01% |
625,030
+195,660
| +46% | +$3.62M |
|
|
ETOR
1440
CALL
eToro Group
ETOR
$2.7B
| $12M | ﹤0.01% |
+180,000
| New | +$11.6M |
|
1441
CareTrust REIT
CTRE
$9.55B
| $12M | ﹤0.01% |
391,348
+103,085
| +36% | +$2.97M |
|
1442
Cal-Maine
CALM
$3.85B
| $12M | ﹤0.01% |
120,015
+46,186
| +63% | +$4.41M |
|
|
WCC
1443
WESCO International
WCC
$17.9B
| $12M | ﹤0.01% |
64,562
+9,162
| +17% | +$1.51M |
|
1444
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $12M | ﹤0.01% |
100,356
+62,356
| +164% | +$7.36M |
|
1445
Aaon
AAON
$7.31B
| $11.9M | ﹤0.01% |
161,921
-819
| -0.5% | -$71.8K |
|
1446
Reinsurance Group of America
RGA
$15.8B
| $11.9M | ﹤0.01% |
60,180
-20,469
| -25% | -$4M |
|
1447
ONE Gas
OGS
$4.96B
| $11.9M | ﹤0.01% |
166,047
+59,391
| +56% | +$4.46M |
|
1448
Revolve Group
RVLV
$1.73B
| $11.9M | ﹤0.01% |
594,138
+18,703
| +3% | +$379K |
|
1449
CALL
Affirm
AFRM
$25.3B
| $11.9M | ﹤0.01% |
172,200
-27,800
| -14% | -$1.44M |
|
1450
Cedar Fair
FUN
$1.62B
| $11.9M | ﹤0.01% |
391,022
+3,193
| +0.8% | +$107K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.